Monica Bertagnolli, 17th Director of the National Institutes of Health, posted the following on LinkedIn:
“It is understandable that a new administration would pause some of the activities of an agency as new leaders are put in place and new priorities are set in motion. However, preventing NIH from issuing research funding by stopping ongoing grant proposal reviews and the work of congressionally mandated advisory committees required for final funding approval, even temporarily, can have a devastating effect on our nation’s longer-term research productivity and success.”